Connect your AI

Lifecore Biomedical, Inc. LFCR Q3 2026 earnings

Reported March 16, 2026 · Before market open

Revenue$35.2MBeat by $2.0M

EPS-$0.16Beat by $0.11

Revenue estimate$33.1M

EPS estimate-$0.27

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$33.1M

EPS estimate-$0.22

Financials

Q3 2026

Balance sheet

Cash & equivalents$17.5M+223%

Total debt$143.2M+4.3%

Total equity-$14.2M-737%

Total assets$232.2M-2.3%

Valuation & ratios

Valuation

as of 12/31/25

Market cap$269.76M+24.8%

Enterprise value$395.48M+13.6%

Returns & leverage

Current ratio3.5×+0.8×

Versus estimates

Revenue

Q3 2027$23.2MMiss by $2.8M

Q3 2026$35.2MBeat by $2.0M

Q2 2026$31.1MBeat by $4.6M Q4 2025$36.4MBeat by $11.2M Q3 2025$35.2MMiss by $209.3K

Diluted EPS

Q3 2027-$0.43Miss by $0.14 Q4 2026-$0.43Miss by $0.19

Q3 2026-$0.16Beat by $0.11

Q2 2026-$0.29Beat by $0.01 Q4 2025-$0.10Miss by $0.01 Q3 2025-$0.19Miss by $0.05

Ask the moment Lifecore Biomedical, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did Lifecore Biomedical, Inc. report Q3 2026 earnings?: Lifecore Biomedical, Inc. (LFCR) reported Q3 2026 earnings on March 16, 2026 before market open.
What were Lifecore Biomedical, Inc.'s Q3 2026 revenue and EPS?: Lifecore Biomedical, Inc. reported revenue of $35.2M and eps of $-0.16 for Q3 2026.
Did Lifecore Biomedical, Inc. beat estimates in Q3 2026?: Revenue beat the consensus estimate of $33.1M by $2.0M. EPS beat the consensus estimate of $-0.27 by $0.11.
Where can I find Lifecore Biomedical, Inc.'s Q3 2026 SEC filings?: You can read the 8-K earnings release (0001005286-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.